What Labour’s ‘U-turn on lifetime allowance’ means for your pension

Labour could now drop plans to reintroduce the policy

Ensysce Biosciences, Inc. (ENSC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

0.5690

+0.0235

(+4.31%)

At close: 04:00PM EDT

0.5451

-0.02

(-4.20%)

After hours:

06:51PM EDT

Loading interactive chart…

Simply Wall St.
Ensysce Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Ensysce Biosciences ( NASDAQ:ENSC ) First Quarter 2024 Results Key Financial Results Revenue: US$305.7k (down 61% from...
Benzinga
Opioid Developer Ensysce Biosciences Stock Is Shooting Higher Today - Here's Why
Ensysce Biosciences Inc (NASDAQ:ENSC) received an FDA Breakthrough Therapy Designation (BTD) for PF614-MPAR, a next-generation opioid. BTD has been granted to fewer than 300 drugs. It is designed to expedite the development and reviewing of drugs intended to treat a serious condition where preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapies. PF614-MPAR is designed to provide optimal pain relief at prescribed doses yet limit accid